6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe

35-subject trial evaluating safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated BalloonEDEN PRAIRIE, Minn.--(BUSINESS WIRE)--#Acquisition--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that Professor...

Related Keywords

Auckland ,New Zealand ,Australia ,Eden Prairie ,Minnesota ,United States ,Sydney ,New South Wales ,Lugano ,Ticino ,Switzerland ,Ramon Varcoe ,Surmodic Sundance ,Andrew Holden ,Surmodics Inc ,Nasdaq ,Sirolimus Drug Coated ,Professor Ramon Varcoe ,Amputation Prevention Symposium ,Main Hall ,Wales Hospital ,Operating Theatres ,South East Sydney Health ,Northern Region Interventional Radiology Service ,Auckland City Hospital ,Sundance Sirolimus Drug Coated Balloon ,Forward Looking Statements ,Annual Report ,